Clinical Trial

Evaluation of a Mobile Menopause Application

Study acronym: EMMA
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study examines whether a digital app can help women manage symptoms of menopause. A total of 426 women with medically confirmed menopausal symptoms are randomly assigned to either use the app in addition to their usual medical care for 24 weeks, or to continue with usual care alone. The app provides evidence-based content and exercises for multimodal menopause management. Participants are followed up over 24 weeks, with the primary outcome assessed at 12 weeks. The main goal is to evaluate whether the app improves menopause-specific quality of life.
Trial Details
NCT Number NCT07663305
Lead Sponsor Endo Health GmbH
Conditions N95.1 Menopausal and Female Climacteric States
Enrollment 426 participants
Start Date 2026-06
Primary Completion 2027-03 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-06-23